Copyright
©The Author(s) 2015.
World J Gastroenterol. Mar 14, 2015; 21(10): 2949-2958
Published online Mar 14, 2015. doi: 10.3748/wjg.v21.i10.2949
Published online Mar 14, 2015. doi: 10.3748/wjg.v21.i10.2949
Figure 3 miR-133a represses the growth of gastric cancer cells in vivo.
A: Expression level of miR-133a in stable P2GM-miR-133a cells and empty vector-carrying control stable cells (bP < 0.01 vs control); B: Stable cells (1000) carrying either P2GM-miR-133a or an empty vector were plated onto six-well plates, and a colony formation assay was carried out; C: Quantitative analysis of colony numbers (aP < 0.05, bP < 0.01 vs control); D: Stable SGC-7901 cells carrying either P2GM-miR-133a or an empty vector were inoculated subcutaneously into the flanks of nude mice (n = 5 per group); E: Representative graphs of tumor masses harvested from nude mice 24 d after inoculation are shown; F: Tumor weight (aP < 0.05 vs control); G: Growth curves of the tumor volume (bP < 0.01 vs control). The average tumor weight is indicated as the mean ± SEM.
- Citation: Gong Y, Ren J, Liu K, Tang LM. Tumor suppressor role of miR-133a in gastric cancer by repressing IGF1R. World J Gastroenterol 2015; 21(10): 2949-2958
- URL: https://www.wjgnet.com/1007-9327/full/v21/i10/2949.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i10.2949